Welcome to the South Carolina Oncology Society
Welcome to the South Carolina Oncology Society (SCOS)! Our mission is to provide advocacy for cancer patients and to promote standards of excellence for high-quality cancer care.
SCOS is committed to adding clarity to both the clinical and business aspects of oncology care, offering our members access to meaningful, current, and helpful information and education.
What's New @ SCOS:
FDA Approves Gilotrif for Patients with Squamous Cell Carcinoma of the Lung
SCOS Urges CMS to Withdraw Part B Drug Payment Model From Consideration
FDA Approves Imbruvica for the First-line Treatment of Chronic Lymphocytic Leukemia
ACCC Expresses Strong Opposition to CMS Proposed Medicare Part B Payment Model Rule
FDA Approves New Indication for Faslodex® (Fulvestrant)